HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 259 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2019. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $328,542,755 | +6.4% | 2,839,854 | -5.4% | 0.03% | +10.0% |
Q2 2023 | $308,750,488 | +33.4% | 3,001,949 | +41.6% | 0.03% | +20.0% |
Q1 2023 | $231,378,368 | +35.4% | 2,120,014 | +41.2% | 0.02% | +31.6% |
Q4 2022 | $170,857,500 | +62.1% | 1,501,384 | -11.9% | 0.02% | +35.7% |
Q3 2022 | $105,423,000 | -3.6% | 1,703,380 | +24.2% | 0.01% | 0.0% |
Q2 2022 | $109,352,000 | -17.6% | 1,371,016 | +8.8% | 0.01% | -22.2% |
Q1 2022 | $132,634,000 | -12.6% | 1,260,653 | -10.4% | 0.02% | -5.3% |
Q4 2021 | $151,688,000 | +9.6% | 1,407,648 | +11.4% | 0.02% | 0.0% |
Q3 2021 | $138,419,000 | +96.1% | 1,263,648 | +67.7% | 0.02% | +111.1% |
Q2 2021 | $70,572,000 | +13.2% | 753,642 | +11.2% | 0.01% | 0.0% |
Q1 2021 | $62,365,000 | +11.3% | 677,581 | -11.5% | 0.01% | 0.0% |
Q4 2020 | $56,026,000 | -17.0% | 765,899 | -11.9% | 0.01% | -30.8% |
Q3 2020 | $67,540,000 | +217.2% | 869,471 | +127.0% | 0.01% | +160.0% |
Q2 2020 | $21,292,000 | +105.7% | 383,086 | +9.7% | 0.01% | +66.7% |
Q1 2020 | $10,349,000 | -11.5% | 349,358 | +8.2% | 0.00% | 0.0% |
Q4 2019 | $11,692,000 | +48.6% | 322,973 | +11.8% | 0.00% | +50.0% |
Q3 2019 | $7,867,000 | +25.2% | 288,895 | +10.6% | 0.00% | 0.0% |
Q2 2019 | $6,283,000 | – | 261,126 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |